Literature DB >> 27842362

A Simple and Efficient Approach to Construct Mutant Vaccinia Virus Vectors.

Ming Yuan1, Pengju Wang2, Louisa S Chard3, Nicholas R Lemoine4, Yaohe Wang5.   

Abstract

The CRISPR-associated endonuclease Cas9 can edit particular genomic loci directed by a single guide RNA (gRNA). The CRISPR/Cas9 system has been successfully employed for editing genomes of various organisms. Here we describe a protocol for editing the vaccinia virus (VV) genome in the cytoplasm of VV-infected CV-1 cells using the RNA-guided Cas9. RNA-guided Cas9 induces double-stranded DNA breaks facilitating homologous recombination efficiently and specifically in the targeted site of VV and a transgene can be incorporated into these sites by homologous recombination. By using a site-specific homologous vector with transgene(s), a N1L gene-deleted VV with the red fluorescence protein (RFP) gene incorporated in this region was generated with a successful recombination efficiency 10 times greater than that obtained from the conventional homologous recombination method. This protocol demonstrates successful use of RNA-guided Cas9 system to generate mutant VVs with enhanced efficiency.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27842362      PMCID: PMC5226142          DOI: 10.3791/54171

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  36 in total

1.  Identification of genes that are associated with DNA repeats in prokaryotes.

Authors:  Ruud Jansen; Jan D A van Embden; Wim Gaastra; Leo M Schouls
Journal:  Mol Microbiol       Date:  2002-03       Impact factor: 3.501

2.  The danger model: a renewed sense of self.

Authors:  Polly Matzinger
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

3.  Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

Authors:  F Ann Ran; Patrick D Hsu; Chie-Yu Lin; Jonathan S Gootenberg; Silvana Konermann; Alexandro E Trevino; David A Scott; Azusa Inoue; Shogo Matoba; Yi Zhang; Feng Zhang
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

Review 4.  CRISPR-based adaptive and heritable immunity in prokaryotes.

Authors:  John van der Oost; Matthijs M Jore; Edze R Westra; Magnus Lundgren; Stan J J Brouns
Journal:  Trends Biochem Sci       Date:  2009-07-29       Impact factor: 13.807

5.  High-frequency homologous recombination in vaccinia virus DNA.

Authors:  L A Ball
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

6.  Incompletely base-paired flip-flop terminal loops link the two DNA strands of the vaccinia virus genome into one uninterrupted polynucleotide chain.

Authors:  B M Baroudy; S Venkatesan; B Moss
Journal:  Cell       Date:  1982-02       Impact factor: 41.582

7.  Generation of gene-modified cynomolgus monkey via Cas9/RNA-mediated gene targeting in one-cell embryos.

Authors:  Yuyu Niu; Bin Shen; Yiqiang Cui; Yongchang Chen; Jianying Wang; Lei Wang; Yu Kang; Xiaoyang Zhao; Wei Si; Wei Li; Andy Peng Xiang; Jiankui Zhou; Xuejiang Guo; Ye Bi; Chenyang Si; Bian Hu; Guoying Dong; Hong Wang; Zuomin Zhou; Tianqing Li; Tao Tan; Xiuqiong Pu; Fang Wang; Shaohui Ji; Qi Zhou; Xingxu Huang; Weizhi Ji; Jiahao Sha
Journal:  Cell       Date:  2014-01-30       Impact factor: 41.582

8.  Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.

Authors:  Hao Yin; Wen Xue; Sidi Chen; Roman L Bogorad; Eric Benedetti; Markus Grompe; Victor Koteliansky; Phillip A Sharp; Tyler Jacks; Daniel G Anderson
Journal:  Nat Biotechnol       Date:  2014-03-30       Impact factor: 54.908

9.  High-efficiency targeted editing of large viral genomes by RNA-guided nucleases.

Authors:  Yanwei Bi; Le Sun; Dandan Gao; Chen Ding; Zhihua Li; Yadong Li; Wei Cun; Qihan Li
Journal:  PLoS Pathog       Date:  2014-05-01       Impact factor: 6.823

10.  A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9.

Authors:  Ming Yuan; Xuefei Gao; Louisa S Chard; Zarah Ali; Jahangir Ahmed; Yunqing Li; Pentao Liu; Nick R Lemoine; Yaohe Wang
Journal:  Mol Ther Methods Clin Dev       Date:  2015-09-16       Impact factor: 6.698

View more
  6 in total

1.  CRISPR/Cas Gene Editing of a Large DNA Virus: African Swine Fever Virus.

Authors:  Manuel V Borca; Keith A Berggren; Elizabeth Ramirez-Medina; Elizabeth A Vuono; Douglas P Gladue
Journal:  Bio Protoc       Date:  2018-08-20

Review 2.  Latest Advances of Virology Research Using CRISPR/Cas9-Based Gene-Editing Technology and Its Application to Vaccine Development.

Authors:  Man Teng; Yongxiu Yao; Venugopal Nair; Jun Luo
Journal:  Viruses       Date:  2021-04-28       Impact factor: 5.048

3.  Establishing elements of a synthetic biology platform for Vaccinia virus production: BioBrick™ design, serum-free virus production and microcarrier-based cultivation of CV-1 cells.

Authors:  Shuchang Liu; Ludmila Ruban; Yaohe Wang; Yuhong Zhou; Darren N Nesbeth
Journal:  Heliyon       Date:  2017-02-04

Review 4.  CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.

Authors:  Arinze Okoli; Malachy I Okeke; Morten Tryland; Ugo Moens
Journal:  Viruses       Date:  2018-01-22       Impact factor: 5.048

5.  A novel vaccinia virus enhances anti-tumor efficacy and promotes a long-term anti-tumor response in a murine model of colorectal cancer.

Authors:  Na Wang; Jiwei Wang; Zhe Zhang; Hua Cao; Wenli Yan; Yongchao Chu; Louisa S Chard Dunmall; Yaohe Wang
Journal:  Mol Ther Oncolytics       Date:  2020-11-17       Impact factor: 7.200

6.  Efficient Method for Generating Point Mutations in the Vaccinia Virus Genome Using CRISPR/Cas9.

Authors:  Laetitia Boutin; Estelle Mosca; Frédéric Iseni
Journal:  Viruses       Date:  2022-07-18       Impact factor: 5.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.